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ABSTRACT
Objective We used non-invasive high-frequency ultrasound (HFUS) imaging to investigate embryonic brain
development in a mouse model for neural tube defects (NTDs) and non-ketotic hyperglycinemia (NKH).
Method Using HFUS, we imaged embryos carrying loss of function alleles of Gldc encoding glycine decarboxylase, a
component of the glycine cleavage system in mitochondrial folate metabolism, which is known to be associated with
cranial NTDs and NKH in humans. We serially examined the same litter during the second half of embryonic
development and quantiﬁed cerebral structures. Genotype was conﬁrmed using PCR. Histology was used to conﬁrm
ultrasound ﬁndings.
Results High-frequency ultrasound allowed in utero detection of two major brain abnormalities in Gldc-deﬁcient
mouse embryos, cranial NTDs (exencephaly) and ventriculomegaly (corresponding with the previous ﬁnding of post-
natal hydrocephalus). Serial ultrasound allowed individual embryos to be analysed at successive gestational time
points. From embryonic day 16.5 to 18.5, the lateral ventricle volume reduced in wild-type and heterozygous embryos
but increased in homozygous Gldc-deﬁcient embryos.
Conclusion Exencephaly and ventriculomegaly were detectable by HFUS in homozygous Gldc-deﬁcient mouse
embryos indicating this to be an effective tool to study CNS development. Longitudinal analysis of the same embryo
allowed the prenatal onset and progression of ventricle enlargement in Gldc-deﬁcient mice to be determined. © 2017
The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
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INTRODUCTION
The embryonic development of neural tube defects (NTDs) and
other central nervous system (CNS) structural anomalies in
humans is poorly understood. Studying animalmodels inwhich
there are genetic mutations associated with abnormalities of
CNS development are a useful method to determine timing of
in utero pathology and possible therapeutic approaches.
High-frequency ultrasound (HFUS) (30–100 MHz) allows
non-invasive visualisation of embryos within the uterus with a
spatial resolution of <100 μm.1–4 At the high frequencies used
in developmental biology studies, soft tissue ultrasound
penetration ranges from 5 to 10 mm,3 which is sufﬁcient to
imagemouse embryos in utero. Being a non-invasive technique,
HFUS allows serial examination of the same litter during
embryonic development, meaning that structural and
functional embryonic development can be followed in vivo
within the same embryo. Early studies using HFUS have
visualised NTDs at embryonic day 10.5–11.5,3 and more
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recently, exencephaly, a cranial NTD that is the forerunner of
anencephaly, and dilatation of the cerebral ventricles has been
detected at E14.5 using this technique.5 A qualitative and
quantitative evaluation of the volume of the ventricular system
has been performed between E10.5 and 14.5.1 Later CNS
development has not previously been studied using HFUS.
The glycine cleavage system (GCS) is amitochondrial enzyme
complex that participates in mitochondrial folate one-carbon
metabolism through decarboxylation of glycine and transfer
of a one-carbon group to tetrahydrofolate, generating 5,10-
methylene tetrahydrofolate.6 Missense mutations in AMT and
GLDC, encoding components of the GCS have been identiﬁed
in some patients affected by NTDs, including spina biﬁda and
anencephaly, that result from incomplete closure of the neural
tube.7,8 Mutation of GLDC or AMT also cause non-ketotic
hyperglycinemia (NKH), a rare autosomal recessive disease,
characterised by accumulation of glycine in body ﬂuids and
tissues,9 which typically presents in neonates, with lethargy,
myoclonic jerks and respiratory problems, leading to coma
and death.10,11 In approximately 50% of NKH patients, there
are additional structural brain abnormalities detected on
MRI/CT scan during the newborn period such as agenesis and
hypoplasia of the corpus callosum, abnormalities of the
cerebellum and occasional hydrocephalus.11–13
Consistent with a role for AMT and GLDC in human NTDs
and NKH, loss of function of the equivalent mouse genes,
Amt and Gldc, causes a similar phenotype.7,14 For example, in
a Gldc-deﬁcient mouse strain, cranial NTDs occur in
approximately 25% of homozygous mutants. The remaining
homozygotes that are without NTDs show premature lethality
with elevated levels of glycine in blood and urine,14 and
approximately one third develop hydrocephalus. Histological
analysis at E18.5 reveals enlarged lateral brain ventricles
(ventriculomegaly) suggesting that the onset of hydrocephalus
is prenatal.14 However, the pathogenesis and stage of onset of
ventriculomegaly remain unclear. The lack of longitudinal data
on brain development in Gldc-deﬁcient mice is a common
feature of many animal models for genetic disease.
Using the ability of HFUS to provide longitudinal
information in the same embryos, we aimed to characterise
the ultrasound appearance of the developing mouse brain to
follow the onset and progression of exencephaly (cranial
NTDs) and ventriculomegaly, the two main abnormalities that
are typical of Gldc-deﬁcient embryos. We extended the
gestational age range of analysis to perform serial imaging of
the developing brain in individual mouse embryos from the
neurulation period to the end of pregnancy.
METHODS
Animals
Animal studies were performed according to the UK Animals
(Scientiﬁc Procedures) Act 1986 and the Medical Research
Council’s Responsibility in the Use of Animal for Medical
Research (July 1993) at UCL Institute of Child Health and the
Centre for Advanced Biomedical Imaging (CABI), University
College London, London. Mice on a C57BL/6 background
carried loss of function gene-trap alleles of the glycine
decarboxylase gene (here denoted respectively GldcGT1 and
GldcGT2).14 GldcGT1/+ female mice were mated with GldcGT2/+
male mice overnight, and plugs were checked on the following
morning. Embryonic day 0.5 (E0.5) of pregnancy was deﬁned
as morning of the day after overnight mating.
Ultrasound procedures
Pregnant mice were transferred to the imaging centre and
allowed to acclimatise for at least 48 hours before the ﬁrst
ultrasound scan. Ultrasound imaging was performed under
general anaesthesia, induced with 4% isoﬂuorane in oxygen
(1 L/min) and maintained with isoﬂuorane 2% in oxygen
(1 L/min). Embryos were imaged using a Visualsonics Vevo
2100 imaging system (Visualsonics, Canada). The pregnant
mouse was placed on the scan table (Visualsonics), with the
limbs located on in-built ECG electrodes to allow physiological
monitoring. The fur was removed from the abdomen using a
chemical hair remover, and pre-warmed gel was applied as an
ultrasound coupling medium. During the scan, body
temperature was monitored using a rectal probe and
maintained between 35 and 36 °C using an infrared lamp and
heated stage. Respiratory and heart rates were monitored using
external electrodes to monitor well-being and to allow gating of
the acquisition of 3D ultrasound volumes to respiration.
Respiratory gating was used to avoid motion because of
maternal respiratory movements, with a delay of 25% over a
respiratory cycle after each breathing event, before data
acquisition.
Scans were performed using two different microscan linear
array transducers: Vevo 2100 MS550D (22–55 MHz) and
MS700 (30–70 MHz) probes (Visualsonics). Maximum depth
of penetration was 15 and 12 mm with a maximum image
width of 14 and 9.7 mm respectively for the MS550D and
MS700 probes. At the level of geometric focus, the axial and
lateral resolutions were 40 and 90 μm for the MS550D probe
and 30 and 75 μm for MS700 probe. A 3D motor stage
connected both to the transducer and to the Vevo Imaging
station allowed the acquisition of 3D volumes of the embryos
with a step size of 32 μm. At the beginning of each ultrasound
session, the maternal abdomen was scanned (MS550D probe);
the maternal bladder, liver and spleen were identiﬁed and a
3 × 3 grid was drawn on the abdomen with a marker pen. Each
embryo was distinguished in relation to its position in the
uterine horns, its placental insertion and the maternal organs.
Using the highest frequency probe (MS700 probe at E12.5 and
E16.5, and the MS550D probe at E18.5), each identiﬁed embryo
was then examined carefully in 2D for structural abnormalities:
the brain was examined looking for any evident anomaly of the
cerebral ventricles, of the cerebellum and the cortex. A 3D
volume of the brain was then acquired and saved for later
ofﬂine analysis. As far as possible, 3D volumes of the brain
were obtained in the sagittal plane and in the transverse plane
with midline structures equidistant to the skull, to optimise the
identiﬁcation of the ventricle diameters.
Collection of embryos and histology
After the last scheduled ultrasound scan (Figure 1), pregnant
mice were sacriﬁced under general anaesthesia by cervical
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dislocation. The abdomen was opened; the uterus was
removed and placed in Dulbecco’s Modiﬁed Eagle’s Medium
(Invitrogen) containing 10% fetal calf serum. Each embryo
was dissected from the uterus and examined for the presence
of external abnormalities identiﬁed under ultrasound.
Embryos were rinsed in phosphate-buffered saline and ﬁxed
in Bouin’s solution (after removal of the skin for litters at
E18.5). For histological examination, embryos were
dehydrated, embedded in parafﬁn wax, sectioned at 10-μm
thickness and stained with haematoxylin and eosin.
Histological examination of individual embryos was performed
blind to ultrasound qualitative and quantitative data.
Genotyping of experimental litters
Embryos were genotyped by PCR ampliﬁcation of genomic
DNA, isolated from tail tip or limb, as described previously.14
Intron-speciﬁc primers amplify products from wild-type and
heterozygous samples. Use of an intron-speciﬁc primer with
a gene-trap construct-speciﬁc primer generated 602-bp and
325-bp products corresponding to the GldcGT1 and GldcGT2
alleles, respectively.
Manual segmentation and quantitative analysis of cerebral
structures in three-dimensional HFUS images
Ofﬂine examination of 3D volumes of brain structures was
performed blind to genotype, using Vevo 2100 software
(Visualsonics) and/or Amira software (FEI). A qualitative
assessment was followed by manual segmentation of the
structures of interest: mesencephalic vesicle, body of the
lateral ventricles and base of the posterior horn of the lateral
ventricles, fourth ventricle and its choroid plexus and
cerebellum (Figure 2). The cerebral ventricles were recognised
as anechoic ﬂuid-ﬁlled cavities surrounded by brain tissue.
The lateral ventricles were divided into two parts: body of
lateral ventricles and base of the posterior horn according to
established anatomical criteria.15 Although these structures
are connected, the base of the posterior horn and the body
of the lateral ventricles were measured separately as the
spatial resolution of HFUS was not sufﬁcient to allow us to
distinguish their point of connection distinct from the
surrounding tissues. Ventricle volumes were normalised to
the hemisphere size on the same side of the embryo, with
laterality being identiﬁable on the basis of the position of the
embryo in the whole 3D image. In transverse and coronal
HFUS sections, the body of the lateral ventricles was
measured as the part of the lateral ventricles just ventral and
dorsal to the third ventricle. The base of the posterior horn
of the lateral ventricles was recognised at its caudal part, at
the level of the mesencephalic vesicle and fourth ventricle.
The mesencephalic vesicle, precursor of aqueduct of Silvius,
was recognised as a rounded shape ﬂuid-ﬁlled structure in
the posterior part of the brain. The cerebellum was recognised
as an echogenic structure, localized between the caudal part
of the mesencephalic vesicle and the roof of the fourth
ventricle. The fourth ventricle with its choroid plexus was
identiﬁed as the most caudal part of the cerebral ventricular
system.
The body of the lateral ventricles, base of the posterior horn
of the lateral ventricles and the mesencephalic vesicle were
measured in the transverse section (Figure 2), while the
cerebellum and the fourth ventricle with its choroid plexus
were measured in the sagittal section (Figure 2). When one or
both of these sections were not achievable, structures of
interest were measured in the coronal section (Figure 4).
Manual segmentation was obtained by drawing the borders
corresponding to signal intensity transition at the brain-
cerebrospinal ﬂuid interface, with a step size of 0.1 mm. After
segmentation, volume measurements were performed
automatically using Vevo 2100 Workstation Software. Figure 2
shows the volume rendering of the cerebral structures in the
three orthogonal planes. To account for potential variability
in brain size owing to differing developmental stages of litters
of the same gestational age (depending on time of mating),
each absolute volume was normalised with respect to the
cerebral hemisphere diameter. For consistency, the
hemisphere diameter was measured in the same transverse
section as were visualized the mesencephalic vesicle and the
lateral and third ventricles, from the midline to the outer edge
of the parietal bone.
Extraction of morphometric data using manual
segmentation may vary by the same operator under different
circumstances,16,17 and we, therefore, assessed the intra-
observer variability. This part of the study was conducted using
Amira software (FEI), which is not speciﬁc for the Vevo 2100
instrument.
Statistical analysis
Each volume measurement was analysed as an absolute
measurement and after normalisation to the cerebral
hemisphere diameter. One-way ANOVA was used for the
analysis of measured parameters in comparison of multiple
genotypes (Gldc+/+, GldcGT1/+, GldcGT2/+ and GldcGT1/GT2) at
E16.5 and E18.5, with post hoc analysis by Holm–Sidak test.
Pairwise comparisons were made by t-test where only two
genotypes were compared. The obtained proportion of
embryos for each genotype was compared with the expected
Mendelian Ratio using Chi-square test. Differences were
considered signiﬁcant when p < 0.05.
Figure 1 Experimental scheme for longitudinal assessment of brain
development by high-frequency ultrasound (HFUS): arrows indicate
the number of embryos and gestational ages in days at which HFUS
was performed for embryos that were analysed at multiple stages.
Twenty-two embryos were scanned at all three stages (E12.5, E16.5
and E18.5), 13 were scanned only at E16.5, and 18 were scanned
at E16.5 and E18.5
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RESULTS
Accuracy of qualitative and quantitative evaluation of cerebral
structures
Scans were performed at three gestational ages as follows:
E12.5 by which time primary and secondary neurulation have
been completed, E16.5 to study the development of the
cerebellum and the cerebral ventricles and E18.5, to investigate
enlargement of the cerebral ventricles in the Gldc-deﬁcient
mouse model. A total of 56 embryos from nine litters were
imaged by HFUS and collected at the end of the experimental
protocol. Of these, 40 embryos were imaged at two or more
stages of pregnancy with the ﬁnal scan at E18.5 (Figure 1).
The time required for the acquisition of HFUS of the embryos
from each litter was approximately 40 min. There were no
experimental complications or embryonic losses, conﬁrming
that repeated HFUS during pregnancy is feasible in mouse
models.
To quantify intra-observer variability segmentation, analyses
were carried out ofﬂine on the cerebral structures of interest of
ﬁve embryos 1 week apart and with the second analysis carried
out blind to sample identity and in a random order. For
volumes of the various structures determined at E18.5, the
mean coefﬁcient of variation varied from 5.9 to 10.3%, with
the exception of the cerebellum (18.6%) and fourth ventricle
(21%). At E16.5, the mean coefﬁcient of variation for measured
volumes varied from 2.9 to 14.9%, with the exception of the
mesencephalic vesicle (22.8%) and choroid plexus (23.0%).
Figure 2 Manual segmentation of high-frequency ultrasound images: images at E16.5 (A–C) and E18.5 (D–F) illustrate the regions deﬁned
for segmentation. The cerebellum, the fourth ventricle and its choroid plexus (yellow, green and red line, respectively) are measured in the
sagittal plane (A and D). Images in the transverse plane (B, C, E and F) were used to outline the body of the lateral ventricles (light blue lines; B
and E), the base of the posterior horn of the lateral ventricles (blue lines; C and F) and the mesencephalic vesicle (purple line; C and F). G–L
show three-dimensional images of cerebral structures after segmentation at E16.5. G-I show surface rendering of the body and the base of the
posterior horn of the lateral ventricles (light blue and blue, respectively) and the mesencephalic vesicle (purple). J–L show the surface rendering
of the cerebellum (yellow), the fourth ventricle (green) and its choroid plexus (red). Anatomic axes for top view (G and J), side view (H and K)
and front view (I and L) are indicated as anterior–posterior (A–P) and right–left (R–L). Scale bar represents 1 mm in all images
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The embryonic stage and size of the gestational sac affected
the extent to which a morphological examination of the entire
litter was possible. At E12.5, a morphological examination of all
embryos was possible in 100% of pregnant dams. As gestation
advanced and the embryonic dimensions increased, the
evaluation of morphology became more challenging, because
of the closer positioning of the amniotic sacs in the maternal
abdomen or because of embryonic lie (cephalic, breech or
transverse). A morphometric evaluation of the brain structures
was achieved in 92% and 88% of embryos without NTDs at
E16.5 and E18.5, respectively (Table 1). Exencephaly occurred
in eight embryos and was detected by ultrasound on every
occasion (16 out of 16 scans), regardless of the stage of
gestation (Table 1)
All embryos were genotyped at the end of the experiments.
There was no signiﬁcant difference between the observed
distribution of embryos among the four different genotypes
and the expected Mendelian ratio (p > 0.05, χ2 test), suggesting
the absence of early in utero lethality (Table 2). There were no
embryos affected by exencephaly among wild-type or
heterozygous embryos, while exencephaly occurred among
44.4% of compound heterozygous embryos (effectively
homozygous for a Gldc mutation), conﬁrming that loss of Gldc
expression causes cranial NTDs (p < 0.05) (Table 2).
Ultrasound appearance of developing cerebral structures and
exencephaly
A morphological examination of HFUS appearance of normal
cerebral structures throughout embryonic development in
Gldc mice was performed. At E12.5 and later stages, brain
tissues were imaged as echogenic structures surrounding the
cerebral ventricles, which appeared as anechoic ﬂuid-ﬁlled
cavities. It was possible to distinguish the prominent lateral
ventricles and the third ventricles arising from the forebrain
vesicle anteriorly, and the mesencephalic vesicle (future
cerebral aqueduct) arising from the hindbrain vesicle in the
posterior part of the brain (Figure 3A–C). Starting from E16.5,
it was possible to clearly discriminate both the body of the
lateral ventricles and the base of the posterior horns of the
lateral ventricles (Figures 2 and 3C). At these stages, the choroid
plexuses were visible as echogenic structures arising from the
medial wall of the lateral ventricles (Figure 3D) and from the
roof and lateral walls of the fourth ventricle. It was not possible
to discriminate between the plexus of the third ventricle, which
arises from the roof of the pineal recess, and the surrounding
brain tissue (Figure 3D and F).
At all gestational ages examined, midbrain–hindbrain
exencephaly was detected by ultrasound as echogenic soft
brain tissues extruding into the amniotic ﬂuid (Figure 3E and
G) and not covered by the cranial bones that are normally
detectable (e.g. in Figure 3D and F). This ﬁnding was
conﬁrmed by post-mortem examination of the embryos in all
cases.
Longitudinal examination of the cerebral ventricular system by
HFUS
Longitudinal morphometric evaluation of the cerebral
ventricular system (mesencephalic vesicle, body of the
lateral ventricles, base of the posterior horn of the lateral
ventricles and fourth ventricle), the cerebellum and the
choroid plexus of the fourth ventricle was performed at E16.5
and E18.5.
Among wild-type and heterozygous embryos, there was a
signiﬁcant decrease in the volume of the mesencephalic
ventricles, body of the lateral ventricles and fourth ventricle
between E16.5 and E18.5 (Table 3). At the same stages, there
was a signiﬁcant increase in the volume of the cerebellum at
E18.5 compared with E16.5 (Table 3). These stage differences
were apparent both in mean absolute volumes and in mean
volumes normalised to hemisphere diameter.
Among the four genotypes, no signiﬁcant differences were
observed in the volume of the cerebral structures at E16.5
(Table 3), and mutant GldcGT1/GT2 embryos showed
comparable volume changes at E16.5 to 18.5 in the
Table 2 Frequency of genotypes and occurrence of NTDs among offspring of Gldc heterozygous matings
Genotype Gldc+/+ (%) GldcGT1/+ (%) GldcGT2/+ (%) GldcGT1/GT2 (%)
No. collected (%) 16 (28.6) 15/56 (26.8) 7/56 (12.5) 18/56 (32.1)
No. expected (%) 14 (25) 14/56 (25) 14/56 (25) 14/56 (25)
No. NTDs (%) 0 (0) 0/15 (0) 0/7 (0) 8/18 (44.4)
The observed ratio of genotypes did not signiﬁcantly differ from the predicted Mendelian ratio (p > 0.05).
Table 1 In utero ultrasound during mouse development
Embryonic day E12.5 E16.5 E18.5
n No. informative scans (%) n No. informative scans (%) n No. informative scans (%)
Total embryos 25 25 (100) 56 52 (93) 40 36 (90)
Embryos with NTDs 2 2 (100) 8 8 (100) 6 6 (100)
Embryos without NTDs 23 23 (100) 48 44 (92) 34 30 (88)
The total number of embryos scanned at each developmental stage is indicated, together with the number and proportion of embryos per litter for which informative scan images
could be acquired.
NTD, neural tube defect.
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mesencephalic vesicle, fourth ventricle and cerebellum as
observed in the other genotypes (Table 3). In contrast, Gldc-
deﬁciency was associated with a signiﬁcant increase in the
volume of the body of the lateral ventricles as gestation
advanced (instead of a reduction in volume as observed in wild
types). As a result, the mean volume of the body of the lateral
ventricles was signiﬁcantly larger in GldcGT1/GT2 embryos at
E18.5 than in the Gldc+/+ group (Table 3). Analysis of the
quantitative data as well as qualitative examination of 2D
HFUS images of individual embryos at E16.5 and 18.5 showed
that the difference in mean volume of the body of the lateral
ventricles could be attributed to two of the seven GldcGT1/GT2
embryos (Figure 4E), accounting for the large intra-group
variability (Table 3).
Conﬁrmation of HFUS ﬁndings by histology
Within the group of GldcGT1/GT2 embryos analysed at E18.5, the
two that exhibited enlargement of the body of the lateral
ventricles on quantitative analysis also had an apparent
enlargement of the third ventricle on 2D images (Figure 4D).
In these two embryos, both the morphology and the volume
assessment of the other brain regions did not show any
obvious difference compared with wild-type embryos
(Table 3). Further detailed qualitative analysis of the cerebral
ventricles at E16.5 showed that in one of the two embryos that
later developed enlarged ventricles, a mild enlargement of the
third ventricle was already visible (Figure 4A). The volume of
this part of the ventricular system was not systematically
measured because of its small dimension in the unaffected
embryos.
The ultrasound ﬁndings were conﬁrmed by histology at
E18.5: a clear enlargement of the lateral and third ventricles
structures above the fourth ventricle was evident in GldcGT1/
GT2 embryos that showed HFUS abnormalities when compared
with Gldc+/+ littermates (Figure 4G–H compared with J and K).
In contrast, GldcGT1/GT2 embryos with normal HFUS ﬁndings
showed similar histology to Gldc+/+.
DISCUSSION
Because of its non-invasive nature, in vivo applicability to
small animals and the high lateral and longitudinal spatial
resolution with a tissue penetration of about 10 mm, HFUS
has been recognised as an excellent imaging technology to
follow in utero embryonic development in mice.1,17,18 In this
study, we have used HFUS to characterise the phenotype of
Gldc-deﬁcient mice, with subsequent conﬁrmation of the
HFUS ﬁndings by histological analysis. NTDs and
hydrocephalus have both been associated with GCS mutation
in humans,7,11,13 and we previously reported the
corresponding presence of cranial NTDs and enlarged cerebral
ventricles in Gldc mutant mice.14 However, the stage at which
hydrocephalus develops in the mouse model had not been
established, and this was complicated by the partial
penetrance of this defect, which means that affected embryos
could not be reliably identiﬁed soon after onset. The
application of longitudinal HFUS, which allows retrospective
analysis of those embryos that later exhibit a phenotype,
highlights the potential value of this technique in
understanding the pathogenesis of animal models for
disease.
As shown at earlier stages,19 longitudinal evaluation during
development was feasible by mapping each embryo, at
different embryonic stages, relative to the position of the
placenta within the amniotic sac and relative to the position
of each sac in relation to maternal structures such as the
bladder. In our study, we also used other maternal landmark
structures such as the liver and spleen, and the embryo
position within the uterine horn to allow us to follow the
development of each embryo through serial ultrasound scans
Figure 3 High-frequency ultrasound imaging of wild-type and
Gldc-deﬁcient embryos: transverse sections of wild-type embryos
at E12.5 (A), E15.5 (B) and E16.5 (C) show the normal appearance
of the mesencephalic vesicle (future aqueduct), the forming cerebral
ventricles (arrows) and surrounding brain tissues. Coronal sections
through the brain of a wild-type embryo (D and F) analysed at both
E16.5 (D) and E18.5 (F) illustrate the progressive reduction of volume
of the body of the lateral ventricles with development. The choroid
plexuses (CP) are detectable within the body of the lateral ventricles
(arrows in D). The ultrasound appearance of exencephaly in Gldc
GT1/GT2 embryos was similar at E16.5 (E) and E18.5 (G); arrows
indicate the protrusion of the brain tissues in E and G. (III, third
ventricle; scale bar represents 1 mm)
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across gestation, and to recognise each embryo when dissected
from the uterus at the end of gestation. We were able to
correctly match ultrasound images with histological sections
and genotypes. In this way, serial HFUS can be used to
reduce the number of animals needed for phenotypic
characterisation, in accordance with the philosophy of the
3Rs model of Russel and Burch (reﬁnement, reduction and
replacement). 3D reconstruction of embryo images also allows
quantitative assessment of the structures of interest.
Mouse brain development has previously been studied from
E10.5 to E14.5 using HFUS anular array.1 In that study,
approximately 50% of each litter was imaged, using semi-
automatic segmentation of the whole ventricular system and
subsequent normalisation of the ventricular volume to the
volume of the whole head. In contrast in our study, we
manually segmented the different parts of the ventricular
system to better measure speciﬁc parts of the developing
embryonic brain. We chose to obtain the 3D volumes with
the skull in transverse section and in the midline so as to
optimise reproducibility of the measurement, similar to the
method used for clinical fetal imaging. The analysed volumes
were then normalised to the ventricular hemisphere diameter
rather than the total head volume to reduce the effect of
non-encephalic structures on the measurement. At E12.5, the
lateral and third ventricles and the mesencephalic vesicle
could all be identiﬁed. At later stages (E16.5 and E18.5), we
could additionally identify the fourth ventricle with its choroid
plexus and the cerebellum. Being ﬂuid-ﬁlled hypoechoic
cavities, the cerebral ventricles and mesencephalic vesicle
were all amenable to volume measurements at E16.5 and
E18.5, with the exception of the third ventricle. In contrast,
because of the similar echogenicity, it was much harder to
distinguish the cerebellum volume from the adjacent
structures, making this measurement in our opinion less
accurate and reproducible.
At E12.5 and subsequent stages, irrespective of the position
of the embryos and the probe used, we were able to identify
exencephaly as a defect of the skull with exposure of brain
tissue to the amniotic ﬂuid. The exencephaly–anencephaly
sequence is characterised by the progressive disruption of
brain tissues exposed to the amniotic ﬂuid with the production
of a ﬁbrotic and haemorrhagic mass with no functional
cerebral cortex. In human embryos, this process is reﬂected
by the change of the appearance of the brain on ultrasound
throughout the pregnancy: in the ﬁrst trimester, brain tissues
that are not covered by the skull are seen as semicircular
structures ﬂoating in the amniotic ﬂuid in the coronal section
(Mickey Mouse sign),20 while in the second trimester, no brain
tissue is visible above the orbits plane (Frog sign). In the
current study, the HFUS appearance of exencephaly in mouse
embryos did not change from E15.5 to E18.5. A mass of
heterogeneous density above the level of the orbits was still
visible in images at E18.5 and conﬁrmed on macroscopic
examination.
The embryo position in the amniotic sac was one of the
limiting factors in the acquisition of transverse and sagittal-
oriented volumes of the brain, especially at advanced
embryonic stage (E18.5). Orientation of the ultrasound probe
on the embryo was facilitated by extensive use of the tilt
function of the imaging table and altering the angle of the
probe. In this way, a suitable image of the brain necessary
for qualitative and quantitative assessment of the structures
of interest was obtained in the majority (88%) of the
analysed embryos at this late gestation stage. When the
desired plane was not achievable during the imaging
acquisition, 3D volumes were acquired to provide a
Table 3 Volume of cerebral structures at E16.5 and E18.5 in wild-type and Gldc-deﬁcient embryos
Cerebral structure Embryonic day
Genotype/normalised volume (mm3 × 102)
Gldc+/+ GldcGT1/+ GldcGT2/+ GldcGT1/GT2
Mesencephalic vesicle 16.5
18.5
30  5
15  2*
34  4
13  1*
35  3
16  2*
30  3
14  2*
Body of the LVs 16.5
18.5
15  2
7  1*
13  2
8  1**
11  1
7  1**
13  3
23  9***
Base of the posterior horn of LVs 16.5
18.5
10  5
11  5
10  2
9  1
13  5
12  3
13  7
9  6
Fourth ventricle 16.5
18.5
14  2
7  1*
12  1
5  1*
14  2
4  1*
10  1
6  1*
Fourth ventricle choroid plexus 16.5
18.5
95  1
10  1
10  1
8  1
11  1
9  4
80  1
10  1
Cerebellum 16.5
18.5
11  0.01
22  2*
13  1
21  3*
15  1
19  1*
12  1
21  2*
The mean normalised volume of the mesencephalic vesicle, body of the lateral ventricles (LVs) and fourth ventricle decreased from E16.5 to E18.5 in wild-type and heterozygous
embryos, while the volume of the cerebellum increased in all genotypes. The mean volume of the body of the LVs increased between E16.5 and E18.5 in homozygous Gldc-
deﬁcient embryos. Number of embryos scanned, n = 13 Gldc+/+, 13 GldcGT1/+, 4 GldcGT2/+ and 9 GldcGT1/GT2 at E16.5 and 11 Gldc+/+, 9 GldcGT1/+, 4 GldcGT2/+
and 7 GldcGT1/GT2 at E18.5. Volumes are mm3 multiplied by 100.
*Signiﬁcantly different to E16.5 of same genotype (p < 0.01).
**Signiﬁcantly different to E16.5 of same genotype (p < 0.05).
***Signiﬁcant difference to wild type at same stage (p < 0.05).
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reconstruction of the images in the three planes, but with
the consequent loss of details in the reconstructed plane.
Moreover, the quality of HFUS images acquired at E18.5
was lower than at E16.5, due to the reduction of the amniotic
ﬂuid that provides natural contrast between the uterine wall
and the mouse embryos. These technical difﬁculties account
for the lower rate of success in the morphometric evaluation
and the larger intra-observer variability with the advancing
gestation. An additional limitation of HFUS is the time of
the acquisition of images for each litter, during which
maternal circulation and body temperature must be
monitored and may be inﬂuenced by the use of general
anaesthesia.
Enlargement of the body of the lateral ventricles in
affected Gldc-deﬁcient embryos was clearly visible in 2D
HFUS images and was conﬁrmed by volume assessment in
the 3D reconstruction of the brain and by post-mortem
histological analysis at E18.5. One embryo, which
subsequently developed enlarged ventricles, showed a mild
enlargement of the third ventricle already present at E16.5
on qualitative examination of 2D images of the brain. This
suggests that the onset of hydrocephalus in this mouse
model is between E16.5 and E18.5, close to the end of the
pregnancy. Strikingly, the HFUS appearance of the fourth
ventricle and its choroid plexus was normal in both the
mutant embryos with enlarged lateral and third ventricles,
Figure 4 Development of ventriculomegaly observed by sequential high-frequency ultrasound and histology: in a GldcGT1/GT2 embryo (A–F)
high-frequency ultrasound imaging of the brain revealed an enlargement of the body of the lateral ventricles at E18.5 (E) that was not evident
at E16.5 (B). Mild enlargement of the third ventricle was also evident (A and D). The fourth ventricle did not appear to change in size from
E16.5 to E18.5 (C and F). (Scale bar represents 1 mm). Histological coronal sections (G–L) in an anterior to posterior sequence (left to right)
through the brain of GldcGT1/GT2 (G–I) and Gldc+/+ (J–L) embryos at E18.5 conﬁrm the abnormal appearance of the body of the lateral
ventricles in the mutant (compare H and K), while the appearance of the fourth ventricle, including the choroid plexus, does not differ (compare
I and L). MV, mesencephalic vesicle; LV, body of the lateral ventricles; PHLV, base of the posterior horn of the lateral ventricles; III, third
ventricle; IV, fourth ventricle; CP, choroid plexus
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and these ﬁndings were conﬁrmed on histological sections.
Because only the structures above the aqueduct of Silvius
were enlarged, we speculated that an obstruction at the level
of the aqueduct might be the cause of hydrocephalus in this
mouse model. At the same time, the analysis of 2D HFUS
images of the base of the posterior horns of the lateral
ventricles did not show any incontrovertible difference
between wild-type and mutant embryos. We hypothesise that
the dilation of this part of the ventricular system might only
be visible later in development or post-natally compared
with the enlargement of the body of the lateral ventricle.
Further work will study in more detail the pathophysiology
of this mouse mutant.
CONCLUSION
This study conﬁrms that both exencephaly and
ventriculomegaly are detectable using HFUS during mouse
embryonic development and indicates this technique to be
an effective tool to study the development of the brain and
the cerebral ventricles in the mouse embryo. Longitudinal
ultrasound assessment is useful to evaluate changes of cerebral
structures throughout fetal life and to detect alterations that
occur at late gestational age.
WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• High-frequency ultrasound (HFUS) has been used to non-
invasively monitor in utero mouse central nervous system
(CNS) development during mid-gestation (embryonic day
10.5–14.5); later gestational ages are yet to be studied.
Missense mutations of the glycine decarboxylase gene
(Gldc) are associated clinically with a metabolic disorder,
non-ketotic hyperglycinemia (NKH) and neural tube
defects (NTDs) such as exencephaly.
WHAT DOES THIS STUDY ADD?
• We extended HFUS imaging of the mouse CNS into late
gestation embryonic day 18.5 in a genetic mouse mutant
lacking Gldc in which NTDs, such as exencephaly, and
hydrocephalus are prevalent. Serial HFUS can determine
the age of onset of ventricle dilation that precedes
hydrocephalus in this model.
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